Company intelligence / Profile preview

Logan Labs

United States

Ownership: Private
Development stage: Other

Overview

Logan Labs developed a high-throughput MRI-based diagnostic technology for rapid and scalable detection of pathogens such as SARS-CoV-2, with 99% specificity and 97% sensitivity, supporting both mobile and lab-based testing. Their platform is in use as a Lab Developed Test (LDT) in the US and is internationally deployed, with expansion and regulatory approval for further pathogens underway.

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic test
Industry: Medical Imaging

Beyond the preview

Go deeper on Logan Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Logan Labs.

Explore the full profile